CLOCK and Alzheimer disease: Moreover, findings from preclinical and clinical studies revealed some roles of melatonin in the control of the circadian clock-associated genes, thus suggesting that the hormone could have beneficial effects in AD patients via an improvement of their circadian rhythms given that AD pathogenesis involves atrophic alterations in the brain resulting in circadian disruptions [38].